Frequencies of genotypes and alleles of the functional SNPs in CYP2C19 and CYP2E1 in mainland Chinese Kazakh, Uygur and Han populations
Authors:
- 15 May 2009
- journal article
- Published by Springer Nature in Journal of Human Genetics
- Vol. 54 (6) , 372-375
Abstract
CYP2C19 and CYP2E1 show great genetic differences between Orientals and Caucasians. The objective of this study was to investigate the genotype and allele distribution patterns of CYP2C19 and CYP2E1 polymorphisms among healthy participants in mainland Chinese Kazakh, Uygur and Han populations by the PCR–restriction fragment length polymorphism technique. The allele frequencies of CYP2C19*2, CYP2E1*5B and CYP2E1*6 were significantly lower in the Chinese Kazakh (15.4, 11.2 and 14.5%, respectively) (PPCYP2C19*3 were similar among the three populations (8.0, 9.4 and 7.2%). Frequencies of the three combined genotypes, one for predicted CYP2C19 poor metabolizers and two for predicted high levels of CYP2E1 transcription, were significantly lower in the Chinese Kazakh (7.5, 19.6 and 28.0%, respectively) (Pχ2-test) and Uygur (8.1, 22.8 and 33.6%) (PCYP2C19 and CYP2E1 genes vary in the Chinese Kazakh, Uygur and Han populations, suggesting that disease susceptibilities or drug responses associated with enzyme activities of CYP2C19 and CYP2E1 may differ in the diverse ethnic populations in mainland China.Keywords
This publication has 16 references indexed in Scilit:
- Drug‐induced liver graft toxicity caused by cytochrome P450 poor metabolismBritish Journal of Clinical Pharmacology, 2007
- Genetic polymorphism of CYP2C19 in Maharashtrian populationEuropean Journal of Epidemiology, 2007
- Comparisons of CYP2C19 Genetic Polymorphisms Between Korean and Vietnamese PopulationsTherapeutic Drug Monitoring, 2007
- Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groupsJournal of Clinical Pharmacy and Therapeutics, 2007
- The high prevalence of the poor and ultrarapid metabolite alleles of CYP2D6, CYP2C9, CYP2C19, CYP3A4, and CYP3A5 in Taiwanese populationJournal of Human Genetics, 2006
- Genetic polymorphisms of ADH2, ADH3, CYP4502E1 Dra-I and Pst-I, and ALDH2 in Spanish men: lack of association with alcoholism and alcoholic liver diseaseJournal of Hepatology, 2004
- Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian populationPharmacological Research, 2004
- Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and the risk of hepatocellular carcinomaJournal of Cancer Research and Clinical Oncology, 2003
- Pharmacogenomics: marshalling the human genome to individualise drug therapyGut, 2003
- Geographical/Interracial Differences in Polymorphic Drug OxidationClinical Pharmacokinetics, 1995